Carna Biosciences Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	924.84	2,108	2,889	3,379	3,817	4,299
Cash & Short-Term Investments	924.84	2,108	2,889	3,379	3,817	4,299
Cash Growth	-59.47%	-27.03%	-14.50%	-11.47%	-11.21%	-12.53%
Receivables	71.17	87	788	182	1,243	129
Inventory	153.65	154	140	118	110	104
Other Current Assets	333.19	388	374	425	148	176
Total Current Assets	1,483	2,737	4,191	4,104	5,318	4,708
Property, Plant & Equipment	-	-	105	100	51	53
Long-Term Investments	52.48	34	51	59	59	70
Other Intangible Assets	-	-	1	1	2	3
Other Long-Term Assets	0	1	1	2	2	1
Total Assets	1,535	2,772	4,349	4,266	5,432	4,835
Accounts Payable	-	2	1	1	2	1
Current Portion of Long-Term Debt	13.41	19	120	151	239	189
Current Portion of Leases	-	8	6	-	-	-
Current Income Taxes Payable	-	180	218	265	332	344
Current Unearned Revenue	-	-	-	-	177	169
Other Current Liabilities	148.2	13	30	19	24	24
Total Current Liabilities	161.6	222	375	436	774	727
Long-Term Debt	451.39	8	28	148	300	239
Long-Term Leases	-	24	28	-	-	-
Other Long-Term Liabilities	58.26	44	42	42	45	45
Total Liabilities	671.25	298	473	626	1,119	1,011
Common Stock	14.85	2,447	2,076	1,382	1,056	558
Additional Paid-In Capital	2,197	6,198	5,827	5,133	4,808	4,310
Retained Earnings	-1,409	-6,253	-4,075	-2,922	-1,572	-1,038
Comprehensive Income & Other	61.95	82	48	47	21	-6
Shareholders' Equity	864.07	2,474	3,876	3,640	4,313	3,824
Total Liabilities & Equity	1,535	2,772	4,349	4,266	5,432	4,835
Total Debt	464.8	59	182	299	539	428
Net Cash (Debt)	460.04	2,049	2,707	3,080	3,278	3,871
Net Cash Growth	-79.31%	-24.31%	-12.11%	-6.04%	-15.32%	-7.57%
Net Cash Per Share	24.12	114.41	161.13	226.18	258.20	314.74
Filing Date Shares Outstanding	19.14	19.1	17.14	16.34	13.48	12.4
Total Common Shares Outstanding	19.14	19.1	17.14	14.21	13.31	12.4
Working Capital	1,321	2,515	3,816	3,668	4,544	3,981
Book Value Per Share	45.15	129.55	226.07	256.14	324.08	308.34
Tangible Book Value	864.07	2,474	3,875	3,639	4,311	3,821
Tangible Book Value Per Share	45.15	129.55	226.02	256.07	323.93	308.10
Order Backlog	-	13.09	39.76	58.12	257.29	214.93

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.